STAT+: MDCalc launches a ‘rumble strip’ for doctors using generative AI tools
Reported by STAT News · all stories from statnews.com
Editorial digest
Medical reference platform MDCalc released a new safeguard aimed at physicians working with generative artificial intelligence. The tool functions as an alert system to help guide clinicians during their interactions with emerging algorithmic technologies.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/5/2026
STAT+: As more doctors consult chatbots, health systems can block them — or buy in
Hospitals must choose whether to restrict or formally integrate conversational artificial intelligence tools increasingly utilized by physicians.
- Trusted health newsroom11/10/2026
STAT+: Men’s use of chatbots for therapy, and earnings season highlights
A new industry report examines male engagement with therapeutic chatbots alongside key takeaways from recent corporate earnings.
- Trusted health newsroom11/10/2026
STAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
Oura plans to purchase Counsel Health in a $625 million deal focused on artificial intelligence healthcare services.
- Trusted health newsroom11/8/2026
STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype
Recent setbacks in cardiovascular medication trials highlight the need for caution regarding artificial intelligence promises in medicine.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom10/20/2026
STAT+: OpenEvidence’s JAMA paper leaves open questions
A recent journal publication regarding OpenEvidence still leaves several unanswered questions in medical technology.